Evidence map›Paper›PMID 21046465›Full record

ArticleAnnals of biomedical engineering2011

Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species.

Rachel Sensenig, Sameer Kalghatgi, Ekaterina Cerchar, Gregory Fridman, Alexey Shereshevsky, Behzad Torabi, Krishna Priya Arjunan, Erica Podolsky, Alexander Fridman, Gary Friedman and 2 more

RetractedAbstract readRetracted Publication
In one paragraph

Article in Annals of biomedical engineering, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Effect of cold atmospheric plasma on changing of biomolecular structures involved in apoptosis pathways of melanoma cancer.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Evaluating the effect of cold plasma on the healing of gingival wound.Journal of diabetes and metabolic disorders · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Rachel SensenigDepartment of Surgery, College of Medicine, Drexel University, Philadelphia, PA 19102, USA.
Sameer Kalghatgi
Ekaterina Cerchar
Gregory Fridman
Alexey Shereshevsky
Behzad Torabi
Krishna Priya Arjunan
Erica Podolsky
Alexander Fridman
Gary Friedman
Jane Azizkhan-Clifford
Ari D Brooks
Drexel University · US

Funding

Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell ActivationR01EB013011 · NIBIB · THOMAS JEFFERSON UNIVERSITY · PI FREEMAN, THERESA A · 2011 to 2014
$1.4M
NIBIB NIH HHS R01 EB013011
6 · The paper itself

Abstract

Non-thermal atmospheric pressure dielectric barrier discharge (DBD) plasma may provide a novel approach to treat malignancies via induction of apoptosis. The purpose of this study was to evaluate the potential of DBD plasma to induce apoptosis in melanoma cells. Melanoma cells were exposed to plasma at doses that did not induce necrosis, and cell viability and apoptotic activity were evaluated by Trypan blue exclusion test, Annexin-V/PI staining, caspase-3 cleavage, and TUNEL® analysis. Trypan blue staining revealed that non-thermal plasma treatment significantly decreased the viability of cells in a dose-dependent manner 3 and 24 h after plasma treatment. Annexin-V/PI staining revealed a significant increase in apoptosis in plasma-treated cells at 24, 48, and 72 h post-treatment (p < 0.001). Caspase-3 cleavage was observed 48 h post-plasma treatment at a dose of 15 J/cm(2). TUNEL® analysis of plasma-treated cells demonstrated an increase in apoptosis at 48 and 72 h post-treatment (p < 0.001) at a dose of 15 J/cm(2). Pre-treatment with N-acetyl-L: -cysteine (NAC), an intracellular reactive oxygen species (ROS) scavenger, significantly decreased apoptosis in plasma-treated cells at 5 and 15 J/cm(2). Plasma treatment induces apoptosis in melanoma cells through a pathway that appears to be dependent on production of intracellular ROS. DBD plasma production of intracellular ROS leads to dose-dependent DNA damage in melanoma cells, detected by γ-H2AX, which was completely abrogated by pre-treating cells with ROS scavenger, NAC. Plasma-induced DNA damage in turn may lead to the observed plasma-induced apoptosis. Since plasma is non-thermal, it may be used to selectively treat malignancies.

Indexed as

ApoptosisCell Line, TumorHumansMelanomaPlasma GasesReactive Oxygen SpeciesPlasma GasesReactive Oxygen Species

Identifiers

PMID21046465
PMCPMC3268344
OpenAlexW2171062412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.